An estimated 700,000 people die each year worldwide from bacterial infections. New antibiotics, rapid diagnostics, vaccines and other products are urgently needed to treat bacteria that are increasingly resistant to existing antibiotics. This is the challenge adressed by the Combating Antibiotic Resistant
Below you will find the latest news from MVA. You can also sign up to our newsletter MVA Update.
MVA Update is an electronic newsletter providing you with news about MVA and an overview of our events and other relevant events in Medicon Valley. You can also check out our calendar for more information about life science events in the region.
If you have any questions regarding our news section or media inquiries then please contact David Munis Zepernick, Head of Press on +45 2498 1668.
“Ascelia Pharma is in a very exciting phase, especially with our main product candidate Mangoral, which is approaching clinical Phase III development and market launch. Meanwhile, we are continuing the development of our second product candidate Oncoral, which completed Phase
Medicon Valley Alliance´s Chairman of the Board since 2015, Søren Bregenholt, has recently been appointed Chief Business Officer at IO Biotech. Leading Danish life science media, Medwatch, interviewed “Novo Nordisk-veteran”, Søren Bregenholt, about his new position and about going from
Our friends at Synapse – Life Science Connect will be hosting the Copenhagen Life Science Summit ’19 (CLSS) on Thursday, May 9th at The Exchange Hall (Børssalen). A full-day conference that aims to bring together students, recent graduates and professionals to
COBIS-based MVA-member, Japanese oncology company, Daiichi Sankyo, established their Nordic headquarter in Copenhagen last year. This was absolutely no coincidence according to Daiichi Sankyo´s Global Chief of Research and Development, Antoine Yver (standing left), who motivates their decision in a recently
During the World Economic Forum in Davos, Switzerland, the Danish based bioscience company, Chr. Hansen, that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries was ranked as the most sustainable company in the world by the recognized business
More than 70 projects applied for the Bio Innovation Institute Proof of Concept grant of up to DKK 1M. 8 projects were finally awarded a total of DKK 7.5M. Here are the winners. We at Medicon Valley Alliance wish them the best
Municipality of Ballerup, MVA-member and one of the leading Danish life science municipalities, has just launched a new campaign and promotion video to raise awareness of the opportunity to locate your life science company in the vibrant local life science
Medicon Valley Alliance is part of the new German-Scandinavian cross-border research network project ‘Hanseatic League of Science (HALOS)’ that has been awarded 3.6 million Euro by the European Regional Development Fund INTERREG. The project, which is coordinated by the University